⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
ALT-006152Pre-approval
Deep Ensemble for the Recognition of Malignancy (DERM)
Skin Analytics Limited · Sponsor
Regulatory Pipeline
1
Proof of Concept2
Development3
Clinical Trial4
Pre-submission5
Submitted6
Under Review7
ClearedAll identifiers (2)
Aletia (canonical)
ALT-006152ClinicalTrials.gov (primary)
NCT04116983Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent Skin Analytics Limited, you can claim this listing to add funding, team, and contact details.
Claim this listing →Clinical Trial Signal
NCT04116983 ↗
completed
Effectiveness of an Image Analysing Algorithm (DERM) to Diagnose Non-melanoma Skin Cancer (NMSC) and Benign Skin Lesions Compared to Gold Standard Clinical and Histological Diagnosis
Phase: na572 enrolledGB
Investor Interest
Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.
0
investors